New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel.

Generic drug maker Apotex Inc. caught the market by surprise yesterday, launching a cheaper copy of the best-selling, blood thinner Plavix in the United States ahead of a likely patent infringement ...

PARIS/LONDON, Oct 5 (Reuters) - French drugmaker Sanofi-Aventis is preparing to sell its own generic version of the blockbuster heart medicine Plavix in France, a company spokesman said on Monday.

Bristol-Myers Squibb and Sanofi-Aventis have filed an injunction against Apotex to stop the Canadian drug maker from selling a less expensive, generic version of the blood thinner Plavix. In the ...

WASHINGTON (AP) – Cheaper generic versions of blood thinner Plavix, the world’s second-best-selling medicine, have just been approved for sale. The Food and Drug Administration says it’s given seven ...

The Justice Department is investigating a deal between two large brand-name drug makers and a generic company. The deal allegedly was made to keep a cheaper, generic form of Plavix off the market for ...

Bristol-Myers Squibb Co. (BMY) and Sanofi-Aventis (SNY) now have the upper hand in an upcoming patent trial over their blockbuster heart drug Plavix, if Thursday’s court injunction in the case is any ...

PARIS, Oct 31 (Reuters) - Sanofi-Aventis posted a better than expected third-quarter profit on Tuesday due to generic rivalry to heart drug Plavix and government health cuts. The world's third-largest ...